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Abstract 
The implantable cardioverter defibrillator (lCD) is the most effective 
treatment available for terminating potentially life-threatening ventricular 
fibrillation and ventricular tachycardia. The lCD detects and attempts to correct 
these arrhythmias by pacing, cardioversion, and defibrillation thereby providing 
lifesaving therapy to patients at risk for sudden cardiac death. Currently, 150,000 
Americans receive ICDs each year. Although most lCD recipients are men, more 
women are now qualifying for insertion (Stutts, Cross, Conti, & Sears, 2007). 
Despite its established health benefits, lCD implantation is accompanied 
by psychological factors which merit research attention. This study investigated 
the experiences of women who live an lCD. The homogenous, purposeful 
sample consisted of 15 women who had an lCD that was implanted within the 
last three years and were receiving follow-up treatment at the same north Florida 
clinic. Data collection was accomplished through a semi-structured interview 
specific to the areas of pre-implantation, immediate post-implantation, and 
discharge home. Results were transcribed verbatim and then analyzed. Five core 
themes emerged from the transcripts along with multiple subcategories. The 
main themes included: Psychological Reactions, Physical Comfort, Procedural 
Issues, Body Image, and Feelings Regarding a Shock. Information obtained from 
this research is beneficial to nurses providing care to women with ICDs and to 
primary care advanced nurse practitioners in order to improve the overall health 
outcome and ongoing care of these women. 
Chapter I 
Introduction 
Sudden cardiac death (SCD) takes thousands of lives in the United States 
each year. The usual cause of SCD is an unstable, fast ventricular rhythm. 
Ventricular tachycardia (VT) and ventricular fibrillation (VF) are the two 
arrhythmias that cause most of these deaths. When either arrhythmia occurs, the 
heart cannot pump enough blood throughout the body. Unless treatment is 
delivered within a few minutes, death is eminent. Long-term treatment options for 
people who survive life-threatening ventricular rhythms include medications, 
surgery, the implantable cardioverter defibrillator (lCD), or combination of 
treatments. ICDs are devices that sense these life-threatening arrhythmias 
automatically and deliver electrical therapy or lifesaving shock directly to the 
myocardium (Chen, Wu, & Ting, 2003). 
Indicators for treatment with an implantable cardioverter-defibrillator (lCD) 
are expanding allowing more patients to qualify for its insertion. According to the 
2008 American College of Cardiology/American Heart Association guidelines, 
basic criteria that are required before consideration of lCD therapy include; prior 
episode of resuscitated VT and/or VF after exclusion of completely reversible 
causes, left ventricular dysfunction due to a prior myocardial infarction (MI) that 
occurred at least 40 days ago, hypertrophic cardiomyopathy, optimization of 
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medical therapy, and expected survival with a good functional status of at least 
one year (Association for Thoracic Surgery, Society of Thoracic Surgeons, 2008). 
Approximately 150,000 people in the United States receive ICDs each year 
(Stutts, Cross, Conti, & Sears, 2007). Patient reaction to the lCD has been an 
area of interest for researchers since its approval in 1985 (Sola & Bostwick, 
2005). In general, most studies have suggested that implantation and activation 
of the lCD can cause adverse psychological impact on patients. However, since 
recipients of an lCD thus far have been mostly men, study participants have 
coincidentally been mostly men. In research that was inclusive of women, the 
ratio on average was four to one, men to women respectively. 
The occurrence of ICD-specific fears and symptoms of anxiety are 
common psychological symptoms experienced by lCD recipients. These patients 
must cope with the prospect of life-threatening arrhythmias, rely on the device for 
the precise delivery of therapy, and live with the potential for the lCD shock. They 
may experience excessive worry and physiological arousal; in fact up to 38% 
have diagnosable anxiety. Other negative moods, notably anger, also increased 
after lCD implantation and were highest at the time of implantation (Carroll & 
Hamilton, 2008). The shock experience, device malfunction, and death are 
common ICD-specific fears of patients documented in previous research studies 
(Sears & Conti, 2006). 
Purpose 
The purpose of this study was to describe the experiences of women who 
live with an lCD. Study findings will be used to better represent women's issues 
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caused by their lCD implantation which will aid in better preparation and 
treatment of such concerns by health care providers. Responses to women's lCD 
implantation is relevant to nurses since they often prepare patients for this 
experience and are often the first to hear of patients' unpleasant symptoms. 
The framework for this research was based on the theory of unpleasant 
symptoms (TOUS). Implantation of an lCD may subsequently cause a variety of 
symptoms unique to women which are necessary to recognize. The TOUS, 
which is discussed further in Chapter II, focuses on multiple symptoms that 
coincide and relate to one another. According to this theory, additional symptoms 
are more likely to impair cognitive and functional performance. However, when 
one symptom is addressed, others become managed in the process (Gift, 2004 ). 
Chapter II 
Literature Review 
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This chapter will provide an overview of cardiovascular disease, its 
prevalence in the United States (US), and the underlying pathophysiology 
leading into coronary artery disease in general, with particular emphasis on 
sudden cardiac death (SCD). This will be followed by a brief discussion of the 
various treatments of cardiovascular and coronary artery disease with a focus on 
implantable cardioverter defibrillators (lCD) for the prevention of SCD. Finally, a 
review of the available evidence with respect to the patient's physical and 
psychological responses to the implantation of a cardioverter-defibrillator will be 
presented. 
Cardiovascular Disease in the United States 
Cardiovascular disease (CVD) is the leading cause of death in the United 
States. It is defined as any abnormal condition characterized by dysfunction of 
the heart and blood vessels. CVD is common in the general population affecting 
the majority of adults after 60 years of age. A substantial part of CVD progresses 
abruptly from asymptomatic disease to coronary events such as angina pectoris 
(chest pain/pressure/discomfort), heart failure (left ventricular dysfunction), 
cerebrovascular accident (stroke/brain attack), and death. Premature mortality 
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occurs primarily in the part of the population that has more modifiable risk factors 
(Greenland, Knoll, & Stamler, 2003). 
Age and gender differences are prevalent in CVD. For persons over 40 
years of age, the lifetime risk of developing CVD is 49% in men and 32% in 
women. For those reaching 70 years, the lifetime risk is 35% in men and 24% in 
women. For total coronary events, incidence increases steeply with age, with 
women lagging behind men by 10 years. For the more serious manifestations of 
CVD such as myocardial infarction (MI) and SCD, women lag behind men in 
incidence by 20 years. Beyond menopause, the incidence and severity of CVD 
increases abruptly, with rates three times those of women the same age who 
remain premenopausal (Eckel, York, & Rossner, 2004). 
Cardiovascular disease as a diagnostic category includes four major 
areas. One is aortic atherosclerosis and thoracic or abdominal aortic aneurysm. 
A second is peripheral vascular disease manifested by intermittent claudication 
and a third is cerebrovascular disease manifested by cerebrovascular accident 
and transient ischemic attack. The fourth category, coronary artery disease 
(CAD) which is manifested by Ml, angina pectoris, heart failure, and cardiac 
death will be discussed (Eckel, York, & Rossner, 2004). 
Coronary Artery Disease 
Coronary artery disease is an abnormal condition that may affect the 
heart's arteries producing various pathologic effects, especially the reduced flow 
of oxygen and nutrients to the myocardium. The most common cause of CAD is 
atherosclerosis, which is the formation of plaque within a hardened arterial wall. 
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CAD can diminish the myocardium's blood supply until it causes ischemia, where 
the myocardium's cells remain alive but cannot function normally. Persistent 
ischemia or complete occlusion of a coronary artery causes infarction, or death of 
the deprived myocardial tissues. Risk factors for the development of CAD include 
age, genetics, male gender, dyslipidemia, hypertension, cigarette smoking, 
diabetes mellitus, obesity/sedentary lifestyle, increased serum markers for 
inflammation and thrombosis, hyperhomocysteinemia, and infection (McCance & 
Huether, 2006). 
CAD often results in myocardial infarction (MI). This occurs when coronary 
blood flow is interrupted for an extended period of time. Cardiac cells can 
withstand ischemic conditions for approximately 20 minutes before cellular death 
occurs and is followed by tissue necrosis. Structural changes post Ml lead to 
functional irregularities such as decreased cardiac contractility with abnormal wall 
motion, altered left ventricular compliance, deceased stroke volume and ejection 
fraction, increased left ventricular end-diastolic pressure, and sinoatrial node 
malfunction. All of these transformations in combination or unaided often lead to 
heart failure and life-threatening arrhythmias (McCance & Huether, 2006). 
Arrhythmias are disturbances of cardiac rhythm and affect more than 90% 
of individuals post Ml making them the most common complication of MI. 
Arrhythmias range in severity from occasional "missed" or rapid beats to serious 
disturbances that impair the pumping ability of the heart, all contributing to heart 
failure and death (McCance & Huether, 2006). For example, atrial fibrillation 
(AF) is the disorganized electrical activity in the atria characterized by quivering 
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instead of pumping in an organized fashion (Chen et al., 2003). However, since 
AF does not affect ventricular contraction, it can be tolerated by most individuals 
(McCance & Huether). In contrast, a serious arrhythmia that can develop is 
ventricular tachycardia (VT) which consists of at least three consecutive 
ventricular complexes with a rate greater than 1 00 per minute. VT often may lead 
to ventricular fibrillation (VF) which occurs when the ventricles quiver very rapidly 
and beat irregularly instead of in an organized fashion. VF allows little or no 
blood to the body and death occurs if not treated with electrical defibrillation 
within minutes (National Heart Lung and Blood Institute [NLHBI], 2006). 
Patients post Ml are at risk for life-threatening arrhythmias which may lead 
to an unexpected death. When cardiac arrest or cardiac death occurs in this 
manner, it is termed SCD. This phrase is used to describe cardiac arrest with 
cessation of cardiac function, whether or not resuscitation or spontaneous 
reversion occurs; a misleading definition since not all affected individuals actually 
die (Pires, Lehman, & Steinman, 1999). The World Health Organization 
developed a clinical definition of SCD as the sudden collapse occurring within 
one hour of symptoms. However, as implied by the name, SCD is instantaneous 
and most individuals become unconscious within seconds to minutes as a result 
of insufficient cerebral blood flow. There usually are no premonitory symptoms. If 
symptoms are present, they are nonspecific and include chest discomfort, 
palpitations, shortness of breath, and weakness. Each year, between 250,000 
and 450,000 Americans experience SCD, and 95% of them do die within 
minutes. SCD occurs most often in adults in their mid-thirties to mid-forties and 
affects men twice as often as women. Treatment of SCD consists of acute 
resuscitation with electrical defibrillation of most importance followed by long-
term prevention of recurrence by pharmacological and nonpharmacological 
means (NHLBI, 2006). 
Treatment of Coronary Artery Disease 
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Risk reduction is a key component of treatment of coronary artery disease. 
Three risk factors about which the most effort should be made to correct are 
hypertension, cigarette smoking, and blood lipid abnormalities. Control of these 
can significantly reduce the risk of CAD. In addition, control of diabetes mellitus is 
extremely important. Obesity and physical inactivity should be approached in 
correspondence with lipid reduction. Exercise is important for weight reduction 
and regulation of lipids (Edmunds & Mayhew, 2004 ). 
Various pharmacologic treatments of CAD are available. For angina 
pectoris, nitrates are often used. Beta-adrenergic blockers and angiotensin-
converting enzyme inhibitors or angiotensin II receptor blockers are prescribed 
for hypertension and systolic dysfunction management. Antihyperlipidemic 
agents are used to aid in dyslipidemia. Aspirin or other antiplatelet 
agenUanticoagulants are used to aid in anti-thrombus formation (Edmunds & 
Mayhew, 2004 ). 
Patients with arrhythmias can also be treated with medications. In AF, 
patients must remain anticoagulated with aspirin or warfarin. Non-dihydropyridine 
calcium channel blockers, such as diltiazem, and beta-adrenergic blockers, such 
as metoprolol offer control of the ventricular response seen with this arrhythmia. 
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Occasionally, cardiac glycosides such as digoxin are added to decrease the 
ventricular rate also. Patients with more serious arrhythmias, such as VT or VF 
can be treated with antiarrythmic medications. The most common is the class Ill 
antiarrythmic, amiodarone. Amiodarone is used both in emergency situations 
such as during the sudden cardiac arrest and prophylactically for patients at risk 
for lethal arrhythmias. Amiodarone does possess significant risks for adverse 
events however. It carries a black box warning due to its variable absorption and 
its prolonged elimination averaging 60 days. Patients using this medication are at 
risk for pulmonary and/or hepatic toxicity. Opposite of its desired action, is 
amiodarone's proarrhythmic effects including arrhythmia exacerbation, significant 
heart block, or sinus bradycardia (Edmunds & Mayhew, 2004). 
Alternatives to pharmacologic therapy are available for the treatment of 
ventricular arrhythmias. Radiofrequency ablation can be an effective treatment 
for AF and VT. Surgery and cardiac transplantation are also options for certain 
arrhythmias. First line therapy for treatment of SCD is placement of an lCD since 
it has proven more effective for improving survival than any other (Sola & 
Bostwick, 2005). 
/CD Functions and Components 
An lCD can deliver life-saving electrical treatment and may be used to 
help correct an arrhythmia. An lCD is a small electronic device implanted in the 
body to monitor the heart continually. It functions as a pacemaker for slow heart 
rates but when ventricular arrhythmias occur, it treats the rhythm with the specific 
type of electrical therapy required. The three types of electrical therapy are: 
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rapid-pacing, low-energy shock, and high-energy shock. Depending on patient 
needs predetermined with results of an electrophysiology study, electrical 
therapy is delivered via pacing, a shock, or a combination of the two. For 
example, if VT occurs, the lCD may deliver small electrical pacing pulses to 
correct the rhythm which the patient does not feel. If a normal rhythm is not 
restored, the lCD will then deliver a shock. The lCD also records and saves 
information about any therapy delivered which aids in discovering what occurred 
during each episode (Mayo Clinic, 2005). 
There are three elements of the lCD system: sensing electrodes, 
defibrillation electrodes, and the pulse generator. Sensing (or the ability of the 
lCD to "see" intrinsic activity) is accomplished by closely spaced tip and ring 
electrodes that provide high amplitude narrow electrograms. These sensing 
electrodes are positioned transvenously on the right ventricular apical 
endocardium during implantation. The electrodes record normal beats that are 
sufficiently large enough for analysis during ventricular tachycardia and 
fibrillation. Dual chamber ICDs have an additional electrode in the right atrium for 
atrial sensing and pacing. The defibrillation electrodes have a relatively large 
surface area and are positioned to maximize the density of current through the 
ventricular system. The lead systems utilize the "active can" technology in which 
the metal housing of the lCD serves as one of the shocking electrodes, which 
requires that the pulse generator be implanted in the pectoral region. The pulse 
generator, which is about the size of a stopwatch, contains the sensing circuitry 
as well as the high voltage capacitors and battery. After detecting a 
tachyarrhythmia, the pulse generator responds by antitachycardia pacing or by 
delivering low- or high-energy shocks (Sola & Bostwick, 2005). 
/CD Implantation 
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Traditional implantation of an lCD usually requires two incisions. Usually, 
local anesthesia is administered to numb the area of the incisions and 
intravenous sedation medication is used for relaxation and comfort. The lCD lead 
systems are typically placed transvenously via the axillary, subclavian, or 
cephalic vessel through a puncture in the skin. They are passed to the heart 
using X-ray equipment to follow the progress, then are positioned and tested 
before connection to the lCD. Proper functioning is tested by the physician 
shocking the heart in such a way to create a fast ventricular rhythm. The patient 
does not feel the arrhythmia or shock due to the general anesthesia administered 
at this point. The pulse generator is then inserted through a 2-3 inch incision 
created for a subpectoral or subfascial pocket in the left chest wall (a right sided 
implant may be performed but is not preferred). The pocket incision is then 
closed with subcutaneous sutures and steristrips (Mayo Clinic, 2005). 
This particular placement type may pose more of a problem for women 
specifically. Both visible scarring and bulging around the implant site are 
produced by placement of the 78gram/40cm3 device underneath the skin; a 
location women's clothing often leaves exposed. The incision may be swollen 
and red for weeks and after the puffiness subsides, the outline of the generator 
and leads may be seen. The weight of the breast itself may pull and tear on 
incision, making the scar larger still. Practical limitations of bra straps, purse 
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straps, and seat belts may affect the female lCD implant recipient because of this 
location (Sowell, Kuhl, Sears, Klodell, & Conti, 2006). 
Immediate Post-Operative Care 
After lCD implantation, nursing care is imperative. A pressure dressing 
over the lCD incision site is applied for the first 12 hours in order to maintain the 
integrity of the newly constructed body pocket. Hospitalization usually consists of 
one overnight stay. Patients are on bed rest for two to six hours or until the 
following morning in order to prevent slippage of the generator out of the 
surgically formed pocket. Pain in the upper chest area incision may occur. 
Patients are instructed to not raise the arm past shoulder height on the lCD side 
for four weeks in order to avoid misplacing the leads. An arm sling is often 
provided to discourage movement of the affected side's arm for the first post-
operative day since ambulation is expected. Before discharge home, a chest X-
ray is taken to guarantee proper placement remains. The lCD is also interrogated 
to ensure proper function and adjustments are made to settings if necessary 
(Mayo Clinic, 2005). 
Discharge Home 
There are multiple instructions for patients discharged home after 
immediate lCD implantation. Showering is permitted 48 hours post implant and 
the steristrips may be removed in two weeks if still attached. Vigorous activities 
or exercises that cause the arm to be stretched behind or raised above the 
shoulder are prohibited for four weeks which allow formation of scar tissue 
around the lead and lead anchors. Patients are encouraged to wear the sling at 
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bedtime if they are likely to sleep with their arms over their head. Driving is 
restricted until the health care provider allows. Since five to ten seconds pass 
before the lCD senses the arrhythmia and provides a shock, patients may 
become dizzy or lightheaded, which could endanger safety of all drivers (Mayo 
Clinic, 2005). The time of the greatest risk for recurrent events is six months post 
implant which is the normal driving restriction. However, once the lCD 
discharges, the six-month driving restriction is reinstituted (Chen et al., 2003). 
Activity and effects of electrical equipment on the lCD should be 
addressed at discharge. Contact sports are prohibited since an impact can be 
harmful to the lCD even after scar tissue formation. Airport security metal 
detectors will not harm the lCD but may be activated by the device which is why 
the lCD identification card should always be carried. Because of potential 
interference, patients with ICDs must remain farther than eight feet from an arc 
welder and also avoid powerful magnets and any heavy industrial equipment. 
Most providers recommend cellular phones be kept at least six inches from the 
lCD and on the opposite side. lCD recipients must not lean over a running engine 
and can never have a magnetic resonance imaging (MRI) test (Mayo Clinic, 
2005). 
Indications for implantation of an lCD are expanding. The lCD is now 
recommended not only for survivors of sustained VT and/or VF (due to 
successful resuscitation) but for those at high risk for SCD. Generally stated, 
patients who are at risk of developing ventricular arrhythmias, including heart 
failure patients, qualify for an lCD. Increased indications for ICDs are a result of 
their proven superior outcomes compared to pharmacologic therapy. 
Antiarrythmic medications help prevent ventricular arrhythmias but their 
accompanied side effects and toxicity are of concern to patients and providers. 
While an lCD will not prevent lethal ventricular rhythms, it will reverse them as 
they occur without the previously described adverse effects of antiarrythmic 
medications (Chen et al., 2003). 
Evidence of Psychosocial Issues 
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Anxiety is a common finding amongst many studies concerning patients 
with ICDs. A literature review performed by Sears and Conti (2002) surmised 
that it is particularly common, with approximately 24-87% of lCD recipients 
experiencing increased symptoms of anxiety after implantation with up to 38% of 
patients eligible for a clinical diagnosis of anxiety. They stated that as long as the 
lCD is seen as a "shock box," it will remain a significant source of anxiety. They 
also found it likely that lCD recipients will need an amount of psychological 
adjustment evidenced by 9-15% of patients having clinically diagnosed 
depression. Another researcher, Dunbar analyzed transcripts of stories told by 
lCD patients from her previous phenomenological studies in order to obtain a 
description of the experience of living with an lCD after a sudden cardiac death 
(2005). Three themes that emerged, and essentially led to the constitutive 
summary of redefining life while forestalling death were; 1. losing control: 
technology as lifesaving yet changing everything, 2. getting on with living, 
regaining control or conditional acceptance, and 3. creating a new vision, 
transformation or tenuous truce. Both studies' researchers suggested routine 
consideration of psychosocial needs as part of the clinical care of lCD patients. 
They further recommended that advice measurement and interventions should 
focus on patient acceptance of the device. 
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The personal impact of the device on families and/or partners of recipients 
emerged from previous studies. In 2004, Albarran, Tagney, and James 
performed an exploratory qualitative study with interviews of eight partners of 
lCD patients; six wives and two husbands. Through their findings, they 
suggested that partners of lCD recipients progress slowly through various difficult 
and adaptive stages when learning how to best support the patient. Partners start 
by acknowledging the patient's need for the lCD, then reacting to it. The partners 
then tend to safeguard the patient; finally reaching the point when they are able 
to assume control and normalize their lives. Carroll (2006) conducted a 
descriptive qualitative study with ten men and two women in an attempt to 
discover their experiences of returning to sexual activity after lCD insertion. 
Results of semistructured interviews suggested that patients with ICDs 
approached sexual activity with anxiety, apprehension, and varied amounts of 
interest and patterns of activity. All participants expressed a need for more 
information and sexual counseling. The anxiety of the partners of lCD patients in 
this study also often resulted in overprotectiveness of the patient with the lCD. 
In addition to discovering studies which validate psychosocial issues of 
patients with ICDs, causation of these issues and aid in extinguishing them also 
surfaced from the literature review. A randomized, controlled, prospective study 
in the UK investigated the effects of a 12 week comprehensive cardiac 
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rehabilitation (CCR) program on patients with an lCD. Participants included 14 
men and 2 women. CCR appeared not only safe, but it improved exercising 
ability thereby lowering levels of psychological distress. Researchers therefore 
proposed that CCR reduces levels of anxiety and depression of patients with an 
lCD (Fitchett et al., 2003). Also, Tagney (2004) explored the confidence and 
competence of nurses in preparing patients for insertion of an lCD and for home 
life post discharge. She used questionnaires on 152 cardiology-associated 
nurses as her method and sample. Results of her study suggested that nurses 
were not confident in their ability to prepare these patients. Therefore, educating 
the nursing staff for pre-implantation and prescribing CCR post-implantation may 
pose solutions to decreasing the number of psychosocial issues of patients with 
ICDs. 
Less Evidence of Psychosocial Issues 
While performing this literature review, some research findings 
contradicted the idea that patients with an lCD experience psychosocial issues. 
While the majority of research pointed to a psychological problem, some were 
not so clear. 
A recent cross-sectional correlational design study that included 46 
women of the total 17 4 subjects investigated quality of life, mood states, and 
global adjustment after lCD implantation. Researchers found four subscales; 
fear/anxiety, attitude, preparation, and body awareness. Perceived adjustment 
was good for the majority of participants and was unrelated to sex, age, and 
shock experience. They witnessed no gender differences, but noted disparity in 
body awareness, physical functioning, and fatigue (Beery, Baas, & Henthorn, 
2007). 
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Two different groups of researchers in the UK performed two literature 
reviews in order to investigate psychological impacts of lCD implant on patients. 
Both reviews concluded that psychological problems probably result more from 
the underlying disease instead of the direct response to the implant itself. The 
meta-analytic review of 20 studies was conducted at a time when more patients 
were being treated with medication instead of the lCD and so reported no 
significant differences in the psychosocial outcome between lCD patients and 
medication-maintained patients or between pre- and post- implant lCD recipients. 
Researchers pointed out that lCD recipients did report significantly worse 
psychological and psychosocial functioning than other cardiac controls (Burke, 
Hallas, Clark-Carter, White, & Connelly, 2005). The other team paraphrased data 
from a large randomized trial by suggesting," ... lCD therapy is neutral or possibly 
beneficial with regard to QOL and patients can expect to feel as well [or as 
poorly] as they did prior to implantation" (McCready & Exner, 2003, p. 68). The 
researchers from this literature review admitted that lCD patients are at risk for 
adverse psychological symptoms and poor quality of life (QOL) but rarely in 
direct response to the lCD itself. 
Additional contradiction to development of mental concerns of patients 
with ICDs was suggested by another pair of research teams who both performed 
studies concerning changes over time pertaining to quality of life (QOL) and other 
psychologic issues. One study's researchers used a QOL index and Mishel's 
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Uncertainty in Illness Scale. Results of their study were that the overall QOL and 
health/functioning of patients with an lCD were unchanged over time. They did 
point out that the first year post implantation was the most stressful and uncertain 
time since this was before the patients had accepted and adapted to their 
changed situation. The researchers' overall suggestion was that QOL for most 
patients with an lCD was reasonably good after implantation once they had 
passed the first year post implant (Fiemme et al., 2005). The other research team 
utilized a prospective, descriptive, repeated, measures design which consisted of 
questionnaires completed by 19 females and 51 males. They investigated 
changes in perception of health status, psychological distress, and QOL from 
baseline to six months, and then 12 months post implantation. Researchers 
found no significant changes in the physical and mental health composite 
summary scores over the first year. The authors claim their study identified an 
improvement in psychological distress over time with a reduction in negative 
psychological distress from baseline to six months. They recommended further 
research since they confess, " ... the effects of lCD living are not well understood" 
(Carrol, Hamilton, & Kenney, 2002, p. 213). 
Despite nonsupporting evidence of psychosocial issues in patients with an 
lCD in this section, all researchers recommend further research. None of the 
four projects discussed were clear and concise. The fact that the majority were 
all foreign and not very current should be considered. 
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Increased Stress, Risk, and Lack of Women Subjects 
Some study results' dismissal of the idea that patients with an lCD have 
psychological issues might give justification to cease research pertaining to it. 
However, all studies discussed thus far have had an unequal representation of 
women versus men as participants. Also, research has proposed that cardiac 
arrhythmia and increased stress have a positive relationship. While most authors 
recommended more research in this area, all stated that women need 
representation too. 
As noted at this point in this literature review, the UK has a few recurrent 
researchers interested in patient reaction to the lCD, such as Tagney and 
Dunbar. Tagney (2003) had another work of a literature review published on the 
subject. Some of her findings included that fear and anxiety relating to the 
anticipation and unpredictable nature of the lCD shocks are common whether 
patients had experienced a shock or not. She also found a link between adverse 
psychological reactions and prospective predictors for occurrence of subsequent 
arrhythmias and shocks. Another author who noted the relationship between 
increased stress and increased risk of ventricular arrhythmias was Dunbar. She 
reminds other researchers that persistent, negative emotions are associated with 
increased serum levels of catecholamines, which result in vasoconstriction, 
increased heart rate, and automaticity. This stimulates corticosteroids which 
causes decreased healing and potentiates the effects of the catecholamines. 
Hence, higher levels of psychological distress may affect health by increasing the 
risk of cardiac arrhythmias (2005). Therefore, negative emotions may be a 
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cause, not a consequence of arrhythmia events. Both Tagney and Dunbar noted 
the need to further discuss women's issues. 
Further in her literature review, Dunbar commented on the need for written 
women's reactions to the lCD. She noted that being female is one factor 
associated with increased psychological distress and reduced functioning. She 
reported that, " ... the lCD takes on special meaning" (p. 295) for women in 
relation to roles and concerns about childbearing and routine mammograms. 
Compared to men, women have increased pain during recovery due to the 
sensitivity of breast tissue and women's greater use of their arms in daily activity. 
Another recent domestic literature review regarding anxiety and QOL of 
patients with ICDs was done by researchers from the Mayo Clinic. Congruent 
with previous study findings, Sola and Bostwick (2005) stressed the importance 
of attending to the psychosocial issues of patients with ICDs. They justify this 
caution since negative emotions are associated with increases in arrhythmias 
and psychiatric illness can interfere with recovery from medical illness. These 
researchers also stated inconclusiveness of gender-related susceptibility to lCD 
induced psychopathology, with reason that subjects are mostly men. They 
reported that some authors in their literature review suggest that women with 
ICDs have an independent risk of developing mood disorders and experiencing 
decreased QOL. 
The three discussed studies questioned the idea of a relationship between 
psychological problems and cardiac arrhythmias. All of these researchers 
addressed the lack of women subjects. Therefore, more research is needed to 
further clarify these issues. 
Evidence of Women-Specific Issues 
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The clinical effectiveness of the lCD has been well established for treating 
patients with life threatening ventricular arrhythmias. However, as demonstrated 
thus far, available research has mainly involved men. This phenomenon allows 
for study findings to be generalized to all patients allowing for the unique health 
concerns of women in this area to go misrepresented. 
Depression and anxiety are a common finding in studies of patients' 
reactions to lCD implantation. A quantitative study performed in Turkey which 
aimed to evaluate the emotional status of patients with an lCD, indicated the 
presence of depression and anxiety in nearly half of the sample. Subjects noted 
that they had more limited lifestyles and 6% reported that they did not even leave 
their homes after implantation. In females, depression and anxiety levels were 
found significantly higher compared to males, with housewives having the 
highest mean scores. Even though this study had an uneven amount of female 
vs. male subjects (22: 79), the authors were able to suggest that female gender 
was an independent predictor for increased anxiety scores (Bilge et al., 2006). 
Other issues specific to women were pain and sleep. A study of 20 lCD 
recipients performed in Sweden suggested that though sleep disturbances were 
the greatest problem in both men and women, it was significant in women 
(Carlsson, Olsson, & Hertevig, 2002). A more recent and domestic study of 
gender differences in lCD insertion also asserted that women had more sleep 
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difficulties than men. Since increased amounts of pain were noted in the female 
subjects of this study, pain could be a factor in their difficulty in sleeping (Smith, 
Dunbar, Valderrama, & Viswanathan, 2006). 
Previously referenced researchers in this literature review performed yet 
another study of patients' experiences of learning to live with an lCD. The UK 
researchers conducted a qualitative, descriptive study using interviews of eight 
patients; two female, six male. Though all experienced varying degrees of 
psychological, social, and physical adjustment both pre- and post- lCD 
implantation, some issues of pain and sleep were unique to female participants. 
One woman in this study described continued pain from her sub-mammary 
incision site which restricted her sleeping positions for six months after implant. 
She was quoted as, "I was getting a pain under my shoulder blade. I can't lie with 
this arm underneath my breast anymore" (p. 198). She also reported that due to 
this, she had to restrict her bra type worn post implant, specifically no underwire 
bras (Tagney, James, & Albarran, 2003). 
A specific study on women with ICDs was completed in the United States 
by Walker et al. regarding women's unique issues (2004 ). Researchers reported 
that a woman's identity as a caretaker and caregiver might be threatened by the 
actual and perceived activity limitations imposed by the lCD or the underlying 
heart condition. They also found that both reproductive and sexual health are 
important issues for women since 25-50% of female patients with ICDs reported 
concerns in this area. Due to the emphasis on women's physical attractiveness, 
body image was also of concern. The ICD's scar and lump in the pectoral area 
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can become an issue. This is parallel to the previously discussed study where 
one female subject reports that she thinks," ... one breast is higher than the other 
now" (Tagney et al., 2003, p. 199). 
Implanted cardioverter-defibrillator implantation does seem to pose unique 
issues for women. Women share problems of anxiety and pain with men, but 
sleep disturbances, body image, and reproductive health are specific to women. 
There still seems to be an absence of complete, empirical, research data on the 
impact of these concerns. 
Theoretical Framework 
The theory of unpleasant symptoms is an appropriate theory to guide 
research on the experiences of women who live with an implantable cardioverter 
defibrillator. As this literature review demonstrates, most patients living with this 
device experience a variety of unpleasant symptoms. More specifically, research 
shows women have many unique symptoms which could be treated more 
efficiently if this theory was incorporated into their plan of care (Sears & Conti, 
2006). 
The middle range theory that fits this research project is the theory of 
unpleasant symptoms (TOUS). The TOUS was formulated as a result of another 
project, where two researchers, Drs. Linda Pugh and Audrey Gift were in the 
process of defining management of two separate symptom models, fatigue and 
dyspnea, when they noted similar models and interventions could be applied to 
both symptoms with good results. The researchers realized that since their two 
symptoms were so multiplicative, this relationship could be applied to other 
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groups of symptoms as they occur in a dynamic clinical situation, thus the TOUS 
was developed. The TOUS would provide nurses with one model to aid in 
understanding and managing all unpleasant symptoms (Gift, 2004 ). 
Since its development and after a revision in 1997, the TO US can be 
found thoroughly used in research and in the clinical setting. Although not 
conducted to test the theory, several published studies regarding other 
symptoms such as nausea, pain, and additional gastrointestinal symptoms have 
yielded findings consistent with the TOUS. Secondary analyses and subsequent 
studies by the theory's developers and colleagues have contributed support by 
relating it to fatigue during pregnancy, childbirth, and the postpartum period and 
in dyspnea in patients with asthma and chronic obstructive pulmonary disease 
(Lenz, Pugh, Milligan, Gift, & Suppe, 1997). The TOUS has performed well at 
describing, predicting, and explaining similarities of the management of groups of 
unpleasant symptoms. 
Research has suggested that patients with an lCD experience a variety of 
unpleasant symptoms (Sears & Conti, 2006). Therefore, utilizing this theory to 
guide this research was appropriate. Using this theory in the care of women with 
an lCD seems suitable as well since, if a nurse can tackle all or at least group the 
symptoms together in order to treat with the same interventions, patients could 
be managed more efficiently. 
Although this study is qualitative in nature and so has no hypothesis, 
primary, or secondary research questions, assumptions of results were still 
made. According to research, all patients with an lCD experience some amount 
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of depression and anxiety. However, symptoms of pain, difficulty sleeping, and 
decreased quality of life are more significant in women than in men. Studies have 
also shown that women with an lCD have issues specific to them like sexual and 
reproductive health, body image, and changes in their perceived role as 
caregiver (Sowell, Kuhl, Sears, Klodell & Conti, 2006). It was presumed 
therefore, that this study would yield similar findings. 
The TOUS concepts can be applied to this study in reference to prior 
research results. As previously stated, the majority of studies show that women 
must make psychological, social, and physical adjustments to their lCD. This is 
congruent with the minor concepts under influencing factors of physiologic, 
psychologic, and situational of the TOUS. These factors influence symptoms 
which lead to consequences of the symptom experience (Lenz et al., 1997). This 
reciprocal phenomenon has surfaced in research performed regarding women 
with an lCD and was assumed to take place in the study. 
In conclusion, the theory of unpleasant symptoms was an applicable 
concept to guide the research study of the lived experiences of women with an 
implantable cardioverter- defibrillator. Since women with an lCD encounter many 
symptoms pre- and post-implantation, and immediately upon hospital discharge, 
it can be assumed that these symptoms vary. However, with the help of the 
TOUS, management and prediction of these unpleasant symptoms would 
become more obvious. 
Chapter Ill 
Methodology 
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This level one descriptive qualitative study examined the experiences of 
women who live with an lCD. This chapter will provide an overview of the setting 
and sample, methods, and procedures used in the study. Analysis and protection 
of the human subjects are addressed and the incorporation of the theory of 
unpleasant symptoms is provided. 
Setting and Sample 
The sample for this research study was attained from a cardiac clinic in 
northern Florida. The clinic had 236 current lCD patients with 55 of them being 
female at the time of data collection. Because qualitative samples are small in 
size and sampling needs may change as the study progresses, it is important to 
not incorporate too many participants at the onset of the study. Therefore, the 
target population for this study was met with a purposeful, homogenous sample 
consisting of the typical 15 participants used in a thematic analysis (Norwood, 
2000). The inclusion criterion was adult, cognitively intact females who had the 
lCD for less than three years. Exclusion criterion was patients awaiting discharge 
from the hospital after implantation. In order to ensure participant comfort and 
convenience, interviews were undertaken after follow up appointments in a 
private room at the clinic and lasted no longer than 60 minutes. 
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Procedure 
Qualified women were invited into the study by telephone call by an 
appointed staff member of the clinic who was familiar to them (See Appendix A). 
After participants agreed to participate, the date, time, and place of the interview 
were verified. A semi-structured interview schedule developed around the areas 
of pre-implantation, immediate post-implantation, and discharge home was the 
instrument used (See Appendix B). Open ended questions and prompts were 
utilized to help elicit the unique experiences, beliefs, and attitudes of the women 
subjects. In conjunction with the theory of unpleasant symptoms, various 
complaints by the women were captured. After obtaining written informal 
consent, the interviews were tape-recorded and then transcribed. Field notes 
were kept in the case of participants giving further relevant information before 
and after the taped interview. 
Data Analysis 
During data analysis, control and validity issues were addressed. In order 
to maintain truth value, the researcher asserted that the study remained subject-
oriented instead of researcher-imposed. Responses were carefully monitored by 
maintaining a journal and debriefing with a colleague to ensure objectivity. In 
order to declare external validity, the researcher strived for informational 
adequacy and continued to perform careful data-analysis techniques. Fittingness 
was granted once the researcher left a clear decision trail so that any reader can 
follow the progression of the interview, understand the logic, and can arrive at the 
same conclusions as the researcher in interpreting the data. The content of each 
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transcription was independently analyzed in order to obtain the sense, meanings, 
and context of the women's experiences. Selected quotes and textual passages 
were assigned codes and then verified by the thesis chairperson in order to 
validate analysis and interpretation of the participants' experiences (Norwood, 
2000). This process allowed themes and categories to emerge. The 
appropriateness of the theory of unpleasant symptoms as a framework for the 
study then further surfaced. 
Ethical Issues 
Approval for the study was attained from the Mayo Clinic Institutional 
Review Board (IRB) (See Appendix C) and from the University of North Florida 
IRB (See Appendix D). Informed consent was required for all participants and 
was retrieved just prior to the interview (See Appendix E). Also at the initiation of 
the interviews, participants were briefed on the interview procedure and 
reminded that they have the right to withdraw at any time and to refuse to answer 
any of the questions. In order to maintain anonymity, all participants were 
assigned and referred to as a lettered number. All of the recorded tapes were 
destroyed once transcribed. 
Chapter IV 
Results 
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Actual demographics for this study were comparable with the 
researcher's anticipation. Twenty-four eligible women were contacted in order to 
obtain the targeted number of 15 participants. Three women refused, two did not 
return a phone call, three did not meet criteria, and one woman did not show for 
her scheduled interview. All participants were currently receiving care at the 
same clinic and all but three had their lCD implanted by the clinic's affiliated 
electrophysiologists. Forty percent were inserted by a particular surgeon followed 
by another who inserted 20% of the devices. Of the 15 participants, four had 
received a high voltage, symptomatic shock. The majority or nine participants 
were over 65 years of age (yoa); 27% were 79-83 yoa, 33% were 70-74 yoa, and 
20% were 62-69 yoa, and 49-55 yoa respectively. The 15 participants were of 
white race and maintained a mid- to upper socioeconomic status. All had their 
devices for less than three years at the time of data collection. Forty percent had 
lCD implantation three years ago, 33% had it two years ago, and 27% had it less 
than two years before. 
Five core themes emerged from the analysis of the women's transcriptions 
along with multiple subcategories. The main themes include: Psychological 
Reactions, Physical Comfort, Procedural Issues, Body Image, and Feelings 
Regarding a Shock. Discussion of the themes with examples of each are 
provided next. 
Psychological Reactions to the /CO 
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The narratives illustrate an overwhelmingly positive reaction to the 
functions of the lCD. Psychological reactions derived mostly from the interview 
question regarding the ICD's major effect on the participant's life. Eighty percent 
of the participants made some sort of reference to feelings of reassurance of 
having the lCD in case they need it and are the 12 participants discussed here. 
Three of those 12 participants related the ICD's functions to the Emergency 
Medical Service (EMS) surmising that the lCD is more efficient at defibrillation 
since the lCD, " ... would take care of it (a cardiac arrest) immediately instead of 
having to wait for some paramedic to come and do it'" and that, "It would be 
better than 911." One participant referred to her lCD as her" ... own portable 
device" and her own" ... life jacket" implying by the remainder of her discussion 
that she feels secure with the lCD; an idea most of these 12 participants shared. 
Half of the 12 participants referenced under this theme commented on that 
idea of protection but actually say the words "safe" or "secure." For example, 
one woman reported that the lCD " ... is my safeguard ... " while another stated, 
" ... it makes me feel secure." One participant demonstrated strong conviction 
regarding safety by her quote, "I am thinking that if anything goes wrong with my 
heart, the thing will do its number and save me, so you can say I feel safer." 
Satisfaction and reassurance were evident in several transcripts. One woman 
who did not elaborate much except in this area of Psychological Reactions, 
31 
reported that the lCD provided a" ... security of knowing it is there ... if something 
happens, I got it." Yet, another participant was relieved to have her lCD since she 
no longer felt she had to agonize over her risks of SCD reporting that " ... 1 didn't 
have to worry about whether I was having a heart attack every time I felt a twinge 
somewhere ... ! just felt the most amazing sense of relief about that...! feel better." 
Further positive Psychological Reactions were evident in the 12 
participants' transcripts. Many viewed the lCD with a sense of assurance. Two 
women quote the word "insurance" and go on to report that the lCD has already 
saved their lives. One participant remembered exclaiming that she, " ... was going 
to live!" after first receiving the recommendation for the lCD. Five in this group of 
12 used favorable descriptions when commenting on their general reactions to 
the lCD. Words like; "great," "wonderful," "excellent," "grateful," "very blessed," 
"awesome," "thankful," and "satisfying" dominated the majority of their narratives 
regarding this theme. In general, most participants were, " ... glad to have it." 
Multiple participants remarked on the technology of the lCD itself. Two 
participants made references like, " ... the technology is here, it's awesome," and 
"I think it is a great thing myself that you have something that can help you," and 
"they can check you (she referenced lCD interrogations) and find out what is 
going on ... that is very satisfying." Eight of the 12 participants implied that their 
device was "smart." 
While most of the 12 participants discussed under this theme verbalized 
encouraging descriptions of Psychological Reactions to their lCD, some 
demonstrated more neutral views. Along with commenting positively, 33% of the 
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women also reported a lack of worry about the lCD and/or their health, and that 
the lCD, " ... doesn't bother ... " them and that they "don't think about it." Many of 
them implied that if the lCD was what they need, then that "is the way it is." One 
participant gave mixed comments saying, "It really hasn't done much for me." 
She however, went on to very casually say that the ICD's prevention of SCD is a 
good thing and that" ... they are great evidently." Twenty-five percent of 
participants expressed some doubt that their lCD would always help them; 
quoted by one as, "I hope it lasts" and another hesitantly stated, "I guess I feel 
more confident." Within this group of participants, it seemed that the longer the 
participants had the lCD, the less positive comments they had regarding its 
effects on their lives. 
Physical Comfort 
The core theme of Physical Comfort arose mostly from the interview 
questions regarding immediate discharge home after implantation of the lCD. 
Eighty-seven percent of women remarked in some noteworthy manner on 
physical comfort from the implant whether it was immediate post operative or still 
continues today. It is interesting to note that the three participants who had no 
significant remarks regarding pain had their lCD implanted the furthest time ago, 
had a harder time recalling events than the other 12, and were aged 70, 7 4, and 
80 years. 
Four of the 13 women referenced under this theme reported some degree 
of immediate post operative discomfort. Three of those four stated intense 
discomfort by recalling the pain as severe and lasting for an excessive amount of 
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time. Some of their stated feelings post operatively were; " ... really, really quite 
painful,"" ... the pain was terrible," the pain," ... was the worst thing," and " ... it 
lasted so long." One participant, a retired nurse, recalled her immediate 
encounter with the pain as, "Honey, I had to lay down and keep still, just lay in 
bed. I couldn't do anything. I couldn't have a conversation with you, it was so 
bad." She was implanted three years previously, which suggests her experience 
as intense as she recalled the events easily. It is interesting to note that the only 
other nurse who participated in this study was also one of these four participants 
who reported intense postoperative discomfort. 
Some participants recalled specific reactions/occurrences immediately 
post operatively, but with less negative emotion than described in the previous 
paragraph. Two women reported that waking up after the surgery was not painful 
and that the incision was not really uncomfortable. However, they both go on to 
criticize the dressing of the incision, stating, " ... they put a pressure tape on the 
area and it was cutting into me ... that was the only pain I was really having," and, 
" ... it felt funny; all that gauze." One of those two women went on to say that she 
did have some discomfort once the anesthesia wore off. She reported increased 
discomfort from keeping her left arm on pillows in order to abide by the activity 
restriction given to her as she recalled it. 
Two participants voiced concern of addiction to the narcotic pain 
medication prescribed upon discharge. One woman was so apprehensive that 
she did not even fill her prescription, stating she " ... just took Tylenol." The other 
convinced herself that the" ... discomfort could be in my head so I figured I am not 
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going to get addicted to anything ... " She allowed her husband to dispense the 
narcotic at his discretion as if to save her from becoming addicted. 
Three study participants within this group described discomfort related to 
the position or placement of the lCD post operatively and currently. Of interest is 
that the most complaints related to this subcategory of position/placement were 
from one of the three participants who had her lCD implanted by a non-clinic 
affiliated physician. She recalls her initial discovery of the ICD's positional 
discomfort and how it still feels today: 
I could feel it rubbing against my collarbone ... It was painful and it hurt to 
even lie down at night to sleep because of it rubbing on my collarbone. It 
has shifted down a bit and I can put my thumb between the collarbone and 
the lCD now ... If I were lifting something out of the closet I would have to 
be careful because then it really shifts it back up again ... 
She went on to report that she is used to it most of the time. In congruence with 
this particular participant's discomfort while sleeping, two other women had 
similar characterizations which were also in line with previous research (Tagney, 
James, & Albarran, 2003). One woman described a pinching sensation when she 
sleeps on her side and has to," ... get it [the lCD] just right." Another woman 
depicted sleeping as, " ... if I lay on that side, I feel it and it kind of hurts ... l put 
pillows on so there is not so much pressure but you are aware of it that way." 
Thirty-one percent of the participants discussed in this Physical Comfort 
theme depicted the lCD as not causing true pain, but more of a sensation of its 
awareness. One participant reported that after one year of her implant, the 
device itself remains somewhat sensitive. She worries about someone, "bumping 
into it" and that she doesn't, "want anyone to hit it." Another woman who was 
very thin, stated that, "cold weather seems to bother mine ... when I'm cold, it 
seems like it aches." All four mentioned that the seatbelt and/or their bra straps 
currently irritate the lCD site, which is also congruent with previous research 
(Tagney, James, & Albarran, 2003). 
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Twenty-three percent of the women depicted among this core theme 
denied any physical distress related to their lCD. It is important to note that all of 
these women had their devices implanted three years prior to their interviews and 
reported no pain both immediate post operatively and today. One participant 
compared her implant procedure to her open-heart surgery seven months prior 
expectantly describing the lCD implantation as the "easier one." She stated she 
is totally unaware of the lCD unless she physically touches it which then she 
thinks, "Yes, I have this thing in me." Throughout her transcripts, she was 
repeatedly quoted as saying, "It hasn't bothered me at all." Another participant 
was in agreement with those ideals as demonstrated by her stating, "It doesn't 
bother me a bit. In fact, I hardly know it is there sometimes. I feel it if I touch 
myself but it doesn't ever give me any kind of feelings .... it has never bothered 
me." 
Procedural Issues 
A third theme, Procedural Issues, emerged from the transcripts and 
encompassed the highest number of comments. The interview schedule was 
mainly composed of questions regarding pre and post lCD implant and discharge 
home which explains this theme's size. Multiple subcategories surfaced mostly in 
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the area of education and preparedness for lCD implant and will be discussed 
next. All fifteen participants commented in this area and will be represented here. 
Noteworthy discussion from participants' recollected thoughts upon first 
hearing they needed the lCD transpired from 27% of the sample. None portrayed 
any sense of alarm upon learning that they needed the lCD, which was 
incongruent to other research (Bilge et al., 2006). In fact, the most negative 
comment observed was, " ... well naturally I was a little apprehensive ... " However, 
a counterbalance of her opinion was later made with," ... if that is what we 
needed, then that is what we needed." The idea of doing just what the doctor 
suggested was evident in all 27% of the participants discussed under this 
subcategory. One woman who had just rehabilitated after open heart surgery and 
had to have her lCD implanted emergently, stated, "I wasn't upset (when she 
received the recommendation for the lCD) because I knew it wasn't anything to 
worry about." Another participant described her recall of the recommendation as 
threat-like stating, " ... he (the doctor) said you will not leave this hospital alive if 
you do not have that (the lCD) .... so I said, alright, let's get with it!" Still another 
seemed to let the physician take total control of her care as stating, "I would do 
whatever he'd (the doctor) say. It's ok with me." One woman saw her ICD's 
recommendation as more of a contract between her and her doctor as evidenced 
by her statement, "He [the doctor] explained it to me. We agreed on it." 
Six participants commented on the level of information given and amount 
of preparedness they felt pre-operatively regarding the procedure itself. Most felt 
they were well informed and possessed a sense of readiness. One participant 
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was, "not nervous" because, "We (she and the nurses) had various educational 
little summits ... They were very good about explaining things to me. If they 
couldn't, they would get somebody who could ... l think I was well-informed." 
Another woman commented on preparedness stating: 
I was assured that I would be taken care of so I wasn't afraid. I had been 
prepped in a sense of what was coming and what to expect. .. everything 
was discussed ... literally, every minute I was told everything that was 
happening. Actually, I was relaxed. 
All six participants held the nurses responsible for their level of preparedness. 
Even the woman, who had the most negative experience in the sample, had only 
the nurses to thank for any information given. She describes her experience as: 
No one talked to me much about what was going on ... I knew nothing 
about the pacemaker before they put it in ... I think all along the line, 
people assumed someone else was giving me the info and no one was 
giving me the info. I didn't even know enough to ever ask the nurses ... the 
last little nurse helped me so much, she would say, 'what don't you 
understand?' ... I don't' understand anything! I don't know enough to ask 
you any questions I told her. 
Most participants used fond adjectives such as, "amazing," "reassuring," 
"wonderful," "very helpful," "impressionable," and "comforting" when describing 
the pre-procedural nurses which is contrasting to a previous discussed study that 
implied nurses were not confident in their ability to prepare lCD patients (Tagney, 
2004). 
Despite voicing adequate preparation, anxiety levels differed among half 
of the participants. The woman who was post open-heart surgery stated that the 
lCD procedure, " ... made me nervous initially." The two nurses in the sample both 
expressed feelings of anxiety about the procedure and incidentally had the most 
detailed recollection of the events. One described actually being placed in the 
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holding area as, "I remember I was thin then and the table was very cold and 
very hard, and they strapped me in which was pretty scary; you know because I 
pretty much knew what was coming." The other reported, "I was scared to death. 
I was very scared." 
As previously indicated, most of the study's participants mentioned the 
nurses from the clinic, holding area of the hospital, and/or hospital unit in their 
transcriptions when questioned about procedural issues. Half of these 
participants specified a particular nurse from the clinic as the person who 
provided their education. One woman stated, "I love her. .. she was very, very 
encouraging and just answered all of my questions ... she was actually better 
than the doctor to a certain degree." Four women generalized nursing as an 
important, helpful necessity during the lCD implantation. They viewed nursing 
staff as reassuring, informative, and caring and seemed pleasantly surprised by 
the degree of those characteristics. For example, one woman reported," ... there 
are nurses out there I discovered that will give you the information you want." 
Another stated, "You [nurses] don't realize what an impression you make on 
people." Most participants mentioned a nurse at least once throughout their 
interview; mostly without disclosure of his/her name. 
The physician who implanted the majority of this sample's lCD, was 
repeatedly referred to with high regards. He was described as, "an angel," "a rare 
human being," "one of the most reassuring guys in the world," "such a caring 
man," "wonderful," and "a good doctor." Two women reported that they would not 
have had the lCD implanted unless he performed it, evidenced by statements 
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like, "You know, nobody wants anyone but him." His demeanor and going "above 
and beyond his call of duty" seemed to be at least some of the reason he has 
such positive responses. For example, one participant's eyes seemed to light up 
when she described how he personally telephoned her family and reassured 
them, which later proved as very important to her. In fact, most of the women's 
eyes lit up when speaking of him. 
This man was not the only physician the participants spoke of. The 
physician who implanted the next highest amount of I COs was regarded by his 
three patients but with more neutral connotations. He was referred to as, "ok" and 
"very thorough." One participant, as implied previously, claimed that the nurses 
were more informative than he. A different physician was regarded as, 
"absolutely wonderful" by two of his patients in this study. The patient with the 
thoroughly negative experience who was implanted by a physician affiliated with 
another group, exhibited an attitude of betrayal by saying, "I just kept trusting 
them ... those [the doctors] are the people you are supposed to be able to trust." 
She goes on to say that once her care was transferred to the north Florida clinic, 
she had answers and that she feels, "better than I have in two or three years." 
Forty-seven percent of these participants grade their lCD implant 
experience as generally positive. Most say that they have nothing bad to say 
about the staff, hospital, or the clinic which is the reason given that they have 
minimal recollection of the experience. Four participants state in some manner 
that there was, " ... nothing alarming" about the incident and again, attributed that 
to their forgetfulness. One reported, "I just remember being well taken care of ... it 
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was just a sense of almost routine." All those who could not recall the procedure 
were overly apologetic to the interviewer and seemed slightly embarrassed. They 
all went on to say how much they love the clinic. 
Upon exploration of immediate post procedural memories, three 
participants discussed specifications about the wound itself. All expressed 
apprehension regarding the incision with statements like, "I was afraid of looking" 
and, "I had an incision and I know it is there, initially I was very frightened." One 
participant recalled with observed disgust, frustration regarding the dressing of 
the incision, "I couldn't get them to listen- to take off the tape because they kept 
saying it had to be there. Consequently, I have a scar from where the tape was 
cutting me ... " Others' recollections were less negative, just more of a sense of 
acquiring an incision as demonstrated by, "I remember waking up pretty drowsy 
and sore and I had this lump in my chest here (points to site)." Also, "I actually 
felt that weight ... like I was carrying a bowling ball there ... " It seemed that after 
criticizing the wound, participants made sure to conclude with a more positive 
note. For instance, the lady who referred to the lCD as a bowling ball goes on to 
say, " ... but that [the feeling] is gone. That dissipates with a little time." She also 
states that she had "absolutely no problem with the wound." The lady recorded 
as saying that she was afraid of looking at it later reported, "Then when I did look 
at it the very first time after the second week, I thought, that's not your incision-
that's nothing! It really was nothing. It still is nothing." The participant who 
complained of the scar from the dressing contradicts herself as," .... 1 wasn't 
really pleased ... but it heals." 
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A final subcategory of Procedural Issues dealt with restrictions and 
immediate discharge home. Thirty-three percent of the total sample expressed 
opinions regarding driving. Two reported that it was more of an independence 
issue, demonstrated by statements such as, "The horrible thing was that he (the 
doctor) told me that I couldn't drive for six months. I just looked at him and said, 
'six months!' I needed a friend to drive me around" and, "I just wanted to drive 
again. I don't like being dependent on other people. It was a little frustrating ... " 
They did convey understanding of the driving restriction exemplified by the 
comment, "I certainly did not want to become unconscious should that device 
kick in and cause an accident...! understood, but I didn't like it." Others 
questioned what would happen if they were driving and the lCD delivered 
therapy, which seemed to display ongoing concerns with driving but not as a 
restriction per se. Still another participant stated that the driving restriction, 
" ... was not a concern really." 
Twenty percent of the participants under this theme of Procedural Issues 
articulated concerns over immediate discharge home. Activity restriction was one 
of those anxieties. One woman worried about taking a shower while another had 
a hard time remembering to, " ... not reach behind or anything." She went on to 
say that she was in disbelief over the lifting restriction of less than five pounds 
exclaiming, "That's ridiculous! I can't even go to the grocery store! Sugar is a five 
pound sack! Flour is a five pound sack!" Two participants expressed concern 
over electrical considerations and the lCD. For example, they both stated that 
they worried about going through security in the airport since now it would take a 
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longer time and that they had to make sure they carried the correct paperwork 
with them at all times. One woman said it was difficult at first to remember to use 
her cell phone with the opposite hand from the side of the lCD. 
Forty percent of the participants' narratives demonstrated a large amount 
of anxiety upon immediate discharge home while two seemed to display an 
amount of despair. One described the feeling as, " ... you go home and feel like, 
am I going to be alright? Is this thing going to go off? What if I am driving?" The 
other stated, "There was so much I didn't understand .... Should I not push the 
vacuum cleaner? Should I not pick up my grandchild?" Still another stated with 
less anguish, that she didn't understand but that she, "learned on the way." 
Despite anxiety regarding immediate discharge home, 33% of participants 
in the Procedural Issue theme were without apprehension. They stated that they 
felt prepared and that the discharge instructions given to them in the hospital by 
the nurses and the physician were easy to understand. They were well informed 
and felt comfortable leaving the hospital especially since they knew the sequence 
of events to come. Two of the women who had concerns over the driving 
restriction closed with a positive note implying that the restriction was not forever 
and that it worked itself out. All had at least one good thing to say about their 
readiness for discharge home. 
Body Image 
Another core theme, Body Image, emerged from 53% of participants' 
transcripts and will be discussed here. Summarizations with examples of those 
eight particular women's narratives will be represented. These ideas emerged 
43 
spontaneously since there was no specific question related to body image in the 
interview schedule. 
Sixty-three percent of the participants in this theme commented on size of 
the lCD. Two women complained about its dimension but with a sense of 
acceptance since their complaints were mostly from their initial sight of it post-
operatively. For example, one woman reported," ... I was surprised how big it 
was ... It was kind a funny having it, a big hump right there. It was awkward at 
first." The other stated, "I wish it wouldn't be so big and ugly ... but there is nothing 
you can do about that." The remaining three of the five participants discussed in 
this paragraph used words like, "bulgy," "bulky," and that it "sticks way out" when 
describing their ICD's appearance. In relation to how others see the lCD, one 
woman remarked that," ... it still sticks out," and that," ... the kids go 'eww!' when 
they see it." Another participant who seemed the most bothered by the lCD itself 
stated, "It still sticks out a lot and I don't know if most people have a square box 
on their chest." Her lCD was placed in an uncommon, elevated location on her 
chest area due to her breast implants as reported by her. 
Thirty-eight percent of the participants here portrayed issues related to 
clothing after receiving their lCD. One woman joked that she would not be able to 
wear a strapless dress, " ... but at 83 [years old], nobody would look anyway." She 
went on to say that since others can always see her lCD, she is, " ... not going to 
have a neckline (laughs) ... ! am too old for that kind of stuff." In contrast, another 
woman declared, "The worst part is vanity ... so I changed necklines." A different 
participant also used the word "vanity" as the only apprehension she had in 
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regards to her ICD's appearance. Another woman did not alter any of her clothes 
after her implant, stating, " ... little shirts, I wear them." 
Half of the women discussed in this theme of Body Image actually stated 
that they have not had any substantial reactions to their ICD's appearance. For 
example, the woman who wished her lCD was not "so big and ugly" went on to 
say that the way it looks, " ... doesn't bother me a bit in the world." The elderly 
lady who joked about wearing strapless dresses described a relationship with her 
lCD saying, " ... it's a part of me." Another woman said she can feel it with her 
hands but doesn't notice it visually. The eldest participant in this study, 85 yoa, 
said she changed, " ... absolutely nothing" about her clothing after receiving her 
lCD implant. Though eight women mentioned something about body image 
related to their lCD, it seemed that this theme was not as apparent as portrayed 
in previous research (Sears, 2004; Tagney, James, & Albarran, 2003). 
Feelings Regarding a Shock 
The last theme that emerged from the narratives concerned 87% of 
participants' thoughts about defibrillator shocks from the lCD. Of the 15 total 
participants of this study, only 27% experienced an actual symptomatic shock 
that they recall and/or were aware of. Subcategories such as; viewing a shock as 
a warning, knowing what to do if it did happen, apprehension of an incoming 
shock, along with the detailed occurrences from the four women who had the 
shocks will be presented here. 
Eight of the 13 participants who commented noteworthy on defibrillator 
shocks saw them in a positive light. Many expressed feelings of gratitude that 
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they had the lCD since if it shocked them; it was saving their lives. For example, 
one woman reported, " ... I know if my heart stops, you know that is kind of a good 
feeling that it would get kicked." Some shared the same idea that if they were 
shocked, the lCD did "what it was supposed to do" and that it would be okay to 
be shocked since then they would know it was working. Most saw the device as a 
source of protection, similar to the subcategory under Psychological Reactions. 
The participants also viewed a shock as a warning; that they had better 
find out what they are doing incorrectly and change it. Thirty-one percent of the 
women depicted in this theme expressed very similar theories as to why they 
would ever receive a shock even though none had ever had one. For example, 
they reported that if it shocked, then "something bad is going on" and they must 
take initiative to change it since it is their responsibility. For example, one 
woman's response to the interview question of "How do you feel about 
defibrillator shocks from the lCD" is quoted as: 
I would be concerned. Thankful. But I would be concerned that I needed to 
change my diet, regulate pills better, or that I would have to do more ... I 
would be concerned that it was telling me to 'fix something!' And then I 
would have to search it down and find out what to do. 
It is interesting to note that none of the women with this attitude had ever 
experienced an actual lCD shock. 
When asked what they would do if they ever experienced a shock, most 
had someone in mind that they would call initially. One woman reported, " ... 1 
would call family and get people here." Another said," I would call the doctor, my 
daughter- I would call everybody." However, three women sought out validation 
from the researcher that their plan was accurate. Two examples are, "I think that 
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I would know to go and call the doctor- is that correct?" and " ... I would probably 
call the doctor. I wouldn't know what else to do. I am assuming that is the 
procedure? I don't know (looks at researcher for the answer)." 
Thirty-one percent under the Shock theme voiced concern of where or 
when a shock may take place. Two women expressed concern of receiving a 
shock while driving. For example, they were quoted as, "My main concern with it 
was, of course, if I happen to be driving ... you are going to be in trouble" and, " ... 1 
wouldn't want to be driving and cause somebody to get hurt." Even though they 
communicated concerns of being shocked while driving, none drove any less. 
One woman uttered concerns of what she might do to facilitate a shock and if 
she was out in public, "Is this going to jolt me and right in the middle of work or 
right in the middle of church, and what's going to happen?" Along the same idea, 
another woman, who had received a shock stated, " ... I think, oh God, I don't 
know if I should be doing this, but mostly when it (raises her arms) is over my 
head ... so I think about it then. Then I think, oh if this thing ever went off, but 
that's all." Two ladies reported that even though they sometimes think about 
ongoing limitations, the thought of an lCD shock does not restrict their activities; 
summed up by one woman as, "It won't keep me from doing anything. I swim and 
do everything." 
Whether these 13 participants experienced an actual shock or not, all 
voiced at least a small amount of apprehension regarding one. Statements like, 
"It would make me nervous," "I would freak out," and "I would panic probably" 
dominated the narratives in regards to initial reactions to a shock. One woman 
47 
verified her feelings of anxiety towards a shock by saying, "I don't think I would 
enjoy the feeling of the pain being so great it would drive me to my knees." 
Another participant stated that apprehension of a shock, "was one of my worries." 
Three women stated that they hope the lCD "never goes off," however one of 
those three who had had a shock expressed that idea with much more conviction 
by exclaiming, "I hope to hell that it never goes off!" She later goes on to say that 
she thinks about it shocking her again, "once in a while." Another woman 
commented on being shocked again as, "It would be like having an experience of 
being in an automobile accident and going back driving an automobile and it 
would come back." 
Though multiple participants expressed apprehension regarding an lCD 
shock, most went on to also say that they do not continuously think about it. Four 
women stated that the thought of a shock does not bother them and/or they do 
not worry about it. The lady that compared her recollection of her shock to an 
automobile accident reports that that memory," ... gets less as time heals." 
Another woman who also experienced a shock reported that the fear of another 
one, " .. .finally faded after I guess about four months." The lady that reported she 
would initially panic if she was shocked says she wouldn't panic as much now 
since she has received more education regarding its proposed feeling. 
As previously stated, 27% of participants experienced an actual 
symptomatic defibrillation. One woman had little to say regarding its feeling, even 
after much prompting. Her only statement was," ... it got me back on track." 
Another woman had a better detail of the experience as it happened on her way 
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to the dining room of her assisted living facility. A shock was delivered yet she 
still continued to enter the room as described by her as, " ... Oh God, I sort of felt, 
all of a sudden, a sharp pain ... so I sat down ... I said [to her son] I'm fine. So in 
we went [to the dining area] and that was it." She reported later that the shock, 
"didn't hurt," and that, "It wasn't any great shock. It was just a little one," and, 
" ... that's the only time it's ever done it. I'm still hoping it never goes off again." 
A different woman received multiple shocks from her lCD. She reported 
the experience as traumatic since she had one episode where her lCD went off 
three times in ten minutes. She reported that," ... it takes your breath away." She 
was quoted as saying, "somebody described it to me like being kicked in the 
chest by a mule ... it's more like being kicked in the chest by an elephant.. .pretty 
scary experience." She goes on to say that that the lCD did what it was 
supposed to do and that it," ... was not the end of the world." Despite her 
seemingly appreciation for the shock, she admitted that she, "toys with the idea 
of turning it off." 
The last woman in this study with a history of lCD shocks had a more 
detailed recollection of the experience. She described it as a frightening, 
horrifying, distressing, and traumatizing event. She was quoted as: 
I woke up and this thing went- JOLT! Of course, you jump a mile! It is sort 
of like an electrical shock. I can't describe it really. And then it was at 
intervals. It would shock me and then maybe in 15 minutes, it would do it 
again, and again, and again. And that is frightening! 
She went on to illustrate that though the physical feeling was horrible, the 
psychological sensation of not knowing what to do and others around her feeling 
scared was just as dreadful. For example, she recollected the incident as, " ... but 
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it is a very frightening experience and it's because you don't know what's 
happening .... and that was more so because the people around me didn't know 
either." She repeatedly mentioned that her husband could feel the shocks when 
putting his hands on her for comfort which she conveyed as very bothersome to 
her. She stated she finally felt some relief upon arrival to the hospital but that she 
remembers the event very vividly. 
Chapter V 
Discussion 
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Health care providers can utilize the documented experiences of women 
who live with an lCD from this study to better prepare and help manage concerns 
of these patients pre- and post-implantation. Acknowledging that there are needs 
specific to women who have an lCD is important to nursing practice and to any 
female patient's coping mechanism. Responding to concerns regarding lCD 
implantation is relevant specifically to nursing since nurses prepare patients for 
the experience and are often the first to hear of patients' unpleasant symptoms. 
The Theory of Unpleasant Symptoms 
In the theory of unpleasant symptoms (TOUS), three categories of 
variables are recognized: Physiologic Factors, Psychologic Factors, and 
Situational Factors. Within each category, several interrelated aspects should be 
considered and can be applied to multiple scenarios. All of the aspects relate to 
one another and may interact to influence the symptom experience (Gift, 2004). 
The five core themes that emerged from this research can be divided into these 
three categories and will be discussed next. 
Physiological Factors 
Physiological Factors as explained by the TOUS are multiplicative. 
Examples are: normally functioning bodily symptoms, existence of any pathology, 
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trauma occurrence, and level of energy. The core theme of Physical Comfort can 
be categorized here. Any operation can be regarded as a type of trauma as does 
the surgical insertion of an lCD. Women's voiced concerns of pain post 
operatively provide for an example of a normally functioning bodily symptom. The 
women under this theme experienced pain in the incision itself and/or 
generalized discomfort immediate post surgery and some today. It is possible 
that pain can increase the intensity of other symptoms as in the case of one 
patient who reported that due to her pain, she experienced decreased levels of 
energy which also qualifies as an aspect in the Physiological Factor group. 
Another theme from the research that could be applicable under 
Physiological Factors of the TOUS is; Feelings Regarding a Shock. When 
describing the actual sensation of defibrillation from the device, all women 
described it at least as uncomfortable. Most comments were of more intense 
descriptions. The physical feeling of a shock can be classified into this category 
since again, pain can intensify other symptoms. 
Psychological Factors 
Many women from the study experienced aspects of the Psychologic 
Factors category and was an area of focus from two different core themes. The 
first, Procedural Issues, supplied examples of mental states and mood. For 
example, six participants commented on the level of information given, amount of 
preparedness, and subsequently, their mental state before their lCD insertion 
with anxiety. The degree of uncertainty, or mood was observed when the women 
expanded on their appreciation of the nurses' education regarding the lCD 
insertion procedure. 
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Another core theme of Body Image fits into this category of Psychological 
Factors. Many women saw the I CO's size post procedure as negative which 
could be classified as an ineffective response to it as the TOUS explains. The 
reaction to the incision and ensuing scar was demonstrated as unconstructive in 
33% of the sample. Other participants stated they had no substantial reactions to 
the appearance of the device or its scar, which in contrast, could be labeled as 
an effective response which would not intensify the degree of any other 
symptoms. 
Situational Factors 
The core theme, Psychological Reactions can be listed in the third and 
last category of the TOUS, Situational Factors. The fact that the majority of the 
sample were of middle to high socioeconomic status and possessed functioning 
support groups could have affected their lived experiences. All participants had 
direct, easy access to health care and its resources. Only one member of the 
sample was overweight; the others took pride in remaining active. These 
situational factors could have influenced the way they perceived their symptoms. 
Limitations to the Study 
There were multiple limitations to this study. The sample demographics 
could arguably provide for biases. The setting of the interview may have had an 
impact on the answers given by participants. Reasons the patients qualified for 
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the lCD were varied. The rapport established between participant and researcher 
could have played a role on responses given by the women. 
Study participants lacked diversity possibly contributing to bias. All women 
were of white race, over the age of 49, and of mid to high socioeconomic status. 
Inclusion of younger women and of a lower socioeconomic status may have 
provided a more complete representation of the female population receiving lCD 
implantation. 
The majority of the sample received the lCD only as prophylaxis with a 
needed bi-ventricular pacemaker to aid alleviation of symptoms of heart failure, 
not exclusively for treatment of survivors of SCD as the researcher had strived 
for. Therefore, many women's responses to interview questions pertained to the 
improvement the pacemaker made on their chronic illness symptoms, not of the 
shock itself; evident by only 27% of participants ever actually receiving a shock. 
Some women even referred to their lCD as a pacemaker, not an lCD. However, 
the majority of the sample was able to demonstrate the distinction if specifically 
questioned. 
The clinic where the sample was collected has a reputation for striving for 
excellence in education, research, and patient care. All of the participants were 
currently under the care of this clinic and all portrayed a sense of pride in such. 
With that being said, receiving preparation, care, and membership at such a 
renowned institution brings much positivity to the overall opinions of its members. 
For example, every participant made at least one encouraging remark about the 
clinic; most supplied multiple comments. Patients from random institutions may 
have allowed different views on their experiences. 
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The setting of the interview may have interfered with some patients' 
remarks to questions. All participants' interviews took place directly after a follow-
up appointment possibly contributing to melancholy which may have influenced 
their answers. Some of the patients did receive grim news regarding their 
prognosis just prior to the interview. For example, one woman was 
recommended placement on the heart transplant list a few minutes before her 
interview. Another was in the midst of heart failure exacerbation while being 
questioned. It could be argued that the mere showing up for the appointment is a 
reminder of inevitable mortality. This may have guided their answers in that 
multiple members of the sample did not think the lCD was really helping them. 
Answers to the interview schedule could have been swayed by the choice 
of methodology used in the study. The researcher's inexperience in interviewing 
and amount of rapport established could have played a role in how much 
information the participants provided. Thankfully, the sample was probably large 
enough to account for this possibility. The researcher's comfort with and 
fondness of elderly women probably worked to her advantage and as a 
counterpart to her inexperience as an interviewer. However, it still deserves 
mentioning as a limitation since the entire sample was not elderly. Also, in 
congruence with self-report research, answers to interview questions may have 
been influenced by characteristics of how the participant thought she should 
respond and how she wanted to be perceived. 
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Implications for Nursing Practice 
The personal thoughts, opinions, and impressions given by the 15 
participants in this study allow for multiple suggestions to practicing nurses. An 
awareness that some of the women displayed was how much knowledge nurses 
actually possess. Therefore, study results could encourage nurses to take a 
stand for what they know and not be reluctant to share with patients. More than 
any other health care professional, nurses focus on the impact a 
disease/condition has on the daily lives of patients and are therefore in the front 
line in all aspects of lCD implantation. Nurses educate, offer support, and provide 
both physical and mental comfort throughout patients' experiences. 
Many participants appeared to respond better to the nurses than the 
physicians especially immediate post-implant. Since lCD implantation is an 
overnight stay in a hospital, staff nurses are given an ample opportunity to 
educate, reinforce, and prepare patients for the immediate discharge home. 
Patients from this institution do receive much education though a lack of 
understanding and/or recollection of it was apparent in some transcriptions. More 
or repetition of the pre-procedural teaching with a focus on gender should be 
instilled. 
With regards to discharge home, nurses could serve to continue education 
and allow for support. For example, a follow-up phone call to all recipients from a 
nurse may provide assistance and encouragement. Nurses should stay abreast 
of support groups and promote their use. Support groups are available yet, are 
not always taken advantage of especially by women. The option of online 
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international forums should also be encouraged. One such online blog is The 
Zapper (www.zaplife.org) which provides nonprofit information sessions and 
individual postings. Witnessing that many of the entries from this site's chat room 
were made from women, creation of women-specific support groups, whether 
online or in person may be beneficial. 
Several important implications from this study become apparent for the 
Advanced Registered Nurse Practitioner (NP). The majority of NPs practice in 
the primary care setting where most chronic disease conditions are managed. 
Being knowledgeable about sudden cardiac death, cardiac arrhythmias, and 
subsequent treatment with an lCD, will ensure better assessment of patient 
status. It is important for NPs to understand the latest treatment options available 
and how to manage the care of a patient who has a unique device like an lCD. 
They should stay abreast of how it operates, follow up schedules with the 
cardiology staff, and the option to disable the lCD when the time comes. It is 
important not only that NPs have the ability to explain to their female patients 
how an lCD works and how it is inserted, but now with information from this 
study, be able to report what the experiences of living with an lCD is like from a 
female patient's perspective. 
Once the NP is aware of her patient's plan to receive an lCD, she could 
take part in its preparation on regular visits. She might discuss pain medications 
and encourage the patient to ask the electrophysiologist for a type of pain 
medication that has worked for her in the past. Since a few participants 
expressed concern over narcotic addiction, she should mention the need and 
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proper use of pain medication making sure to also speak directly to the family as 
to help alleviate fear and uncertainty. Most participants had issues with the 
incision itself and the ICD's size and weight, therefore the NP should reiterate 
realistic expectations. 
Immediate discharge home was an issue with many of the women in this 
study. The NP is in a position to educate and reinforce driving and activity 
restrictions, making sure to use layman's terms. She could clarify specific actions 
to do or not do as participants articulated in the study such as specific household 
duties, church attending, and handling grandchildren and pets. Promotion of 
involvement of their support systems in their presence since many women 
shared the idea of "burdening" others should be accomplished at these visits. 
Since multiple participants conveyed doubt during the interviews on what to do if 
shocked, the NP should encourage development of a specific plan if the lCD 
administered therapy and continue to remind them and update it on subsequent 
visits. 
Considering how much female patients revere nurses and all they have to 
offer, staff nurses should encourage support groups and discussion with their NP 
about their lCD at the time of hospital discharge home. Since many participants 
in this study demonstrated positive psychological responses to the lCD, the NP 
should encourage and nurture those feelings. However, the NP should not 
discourage expression of pessimistic feelings regarding the lCD. As suggested in 
this study, some patients seemed less enthusiastic as time progressed, so NPs 
could periodically remind them of the ICD's functions. Counseling and coping 
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support should be offered at every office visit. She should be realistic and 
support any decision or exploration of patients' thoughts of disabling the lCD also 
at any time. 
Implications for Future Research 
Further research is warranted to bring awareness to the experiences of 
women who live with an lCD. Few studies here in the US have been conducted 
using a large sample of women specifically on reactions to the lCD. This study 
adds to the research that has identified some unique issues specific to women 
with an lCD. More research can only strengthen these findings and educate 
healthcare professionals regarding these gender specific issues of living with an 
lCD. 
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Appendix A 
Topic of Telephone Script: 
This telephone script will be used to recruit participants into the study. 
Introduction: 
"Hello, this is Jennifer Crain calling from the Mayo Clinic in Jacksonville. May I 
please speak to ___________ ?" 
***If the person is there, continue with the script. 
***If the person is not there, ask when it would be a good time to call to speak 
with ? 
Describe the Reason for the Call: 
(Example of phone call to potential participant) 
I am calling to invite you into a research study we are conducting to help us learn 
about the experiences of women who live with an /CO. Please understand that 
your current or future medical care at the Mayo Clinic will not be jeopardized if 
you choose not to participate. Is this something you would be interested in 
gaining more information about? 
If no: Thank them for their time and stop the recruitment process. 
If yes: The primary investigator, Jenea Smith is a UNF graduate student in the 
Nurse Practitioner Program. She is going to perform one interview with you 
where she will ask you questions about your experiences related to your /CO. 
The interview will last no more than 30 to 60 minutes and will take place at the 
Pacer Clinic. Once you agree to participate, I will set up an interview date and 
time. Of course, whenever possible, I will schedule your interview around the 
time of your next follow-up appointment. Would you like to participate? 
***If questions: Answer questions in order to clarify interview process only. 
***If no questions and in agreement to participate: verify date, time, and place of 
interview. Thank you for participating in our research study. Please understand 
that your answers will remain confidential. Good-bye. 
Appendix B 
Interview Schedule 
PARTICIPANT AGE: __ DATE IMPLANTED: ____ _ 
TIME START: ____ _ TIME END __ _ 
Pre-implantation of lCD 
1. Can you tell me what you remember of the events leading up to you having the lCD 
implanted? 
PROMPTS: 
-Specific/related hospital admission 
-How do you feel about this? 
Post-implantation of lCD 
2. What particular concerns did you have at the time before leaving the hospital? 
3. In what ways were you prepared for discharge home? 
PROMPTS: 
-Any suggestions to nurses who educated you? 
Discharge home 
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4. Think back to when you were first discharged home after implantation of the lCD, how did 
you personally cope during those first few weeks? 
5. What do you recall as your immediate practical concerns at that time? 
6. Overall, what would you say have been the major effects that having lCD has had on 
you? 
lCD shocks 
7. How do you feel about defibrillator shocks from the lCD? 
PROMPTS: 
-Have you experienced one? 
-How do you think it would affect you? 
Appendix C 
Mayo I RB Approval 
Principal Investigator Notification: 
From: IRB 
To: Jenea Smith 
CC: Study Team Members that are marked as wishing to receive correspondence 
regarding the protocol/grant application 
Re: Application# 07-004210 
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Click the link below to access the protocol/grant application information in 
your IRBe workspace, as well as the approved consent document(s)/Rough 
Word consent 
document(s) that need to be used when submitting consent changes as 
part of a modifications request (if applicable) under the Documents tab: 
07-004210 
Please note that all correspondence (modifications, progress reports, reportable 
events) related to this study/grant application must be submitted electronically in the 
IRBe system. 
The following is a REVISED excerpt from the minutes of the Expedited Review A of the 
Mayo Clinic Institutional Review Boards meeting dated 7/17/2007: 
The Committee reviewed and approved for human studies the protocol entitled "The 
Lived Experiences of Women with an Implantable Cardioverter Defibrillator (lCD)." from 
Ms. Jenea Mary Smith. The Committee noted that the human studies aspects involve 
an audio taped interview of female subjects who have had their implantable cardioverter 
defibrillator less than three years. A maximum of 15 adult female participants with an 
lCD are approved for enrollment in this protocol at Mayo Clinic Jacksonville. Due to 
participant contact, written HIPAA authorization and informed verbal consent (which is 
obtained by participants completing the interview) must be obtained. Documentation of 
verbal consent (as a CEN) and a scanned HIPAA form should be placed in each 
participant's medical record. The telephone script and interview schedule were 
approved as written. The HIPAA Authorization form was approved with revisions. The 
IRB office will provide the final approved form on the IRBe workspace for this item. The 
Committee determined that this constitutes minimal risk research, and therefore was 
eligible for expedited review in accordance with 45 CFR 46.11 O(b )(1) and 63 FR 60364, 
item 6. This approval is valid for exactly one year unless during the year the IRB 
determines that it is appropriate to halt or suspend the study earlier. 07-004210 
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This is to advise you that your project, "The Lived Experiences of Women with an 
Implantable Cardioverter Defibrillator (ICD)," has been reviewed on behalf of the UNF 
Institutional Review Board and has been declared exempt from fmiher IRB review. 
This approval applies to your project in the form and content as submitted to the IRB for 
review. Any variations or modifications to the approved protocol and/or informed 
consent fotms as they relate to dealing with human subjects must be cleared with the IRB 
prior to implementing such changes. 
Should you have any questions regarding your exemption or any other IRB issues, please 
contact Nicole Sayers, Assistant Director of Research Integrity, at 620-2498. 
Thank you. 
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RESEARCHER .I PROTOCOL:t:AST APPROVED BY IRB 
Ms. Jenea Smith July 24, 2007 
IRB# 
07-€104210 
THIS FORM APPROVED 
July 24, 2007 
Your privacy is important to us, and we want to protect it as much as possible. By signing this funn, you authorize 
Mayo Clinic and the investigators to use and disclose any information created or collected in the course of your 
participation in this research protocol. This information might be in different places, including your original 
medicru record, but we will only disclose information that is.related to this research protocol for the purposes listed 
below. 
This information wlll be given out for the proper monitoring of the study, checking the accuracy of study data, 
analyzing the study data. and other purposes necessary for the proper conduct and reporting of this study. If some 
of the information is reported in published medical journals or scientific discussions, it will be done in a way that 
does not directly identify you. 
This information may be given to other researchers in this or private, state or federal government parties or 
regulatory authorities (U.S. and other countries) responsible for overseeing this research. These may include the 
Office for Human Research Protections, or other offices within the Department of Health and Human Services, and 
the Mayo Clinic Office for Human Research Protections or other Mayo groups involved in protecting research 
subjects. 
If this information is given out to anyone outside of Mayo, the information may no longer be protected by federal 
privacy regulations and may be given out by the person or entity that receives the information. However, Mayo will 
take steps to help other parties understand the need to keep this information confidential. 
This authorization lastl; until the end of the stud~. 
The study does not end until all data have been collected, checked (or audited) and analyzed. Sometimes this can be 
years after your study visits have ended. 
You may stop this authorization at any time by writing to the following. address: 
Mayo Clinic 
Office for Human Research Protection 
ATIN: Notice ofRevocation of Authorl211tion 
200 lst Street SW 
Rochester, MN 55905 
If you stop authorization, Mayo may continue to use your information already collected as part of this study, but 
will not collect any new information. 
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Authorization to Use and Disclose 
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/ 
I have had an opportunity to have my questions answered. I have been given a copy of this form and 
understand that a copy will be placed In my medical record. 
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UNF IRB Number: 
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